Mosaic Therapeutics appoints Dr Vince O’Neill, MD, as Head of R&DBy Mario Cazombo / April 1, 2026 – Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team Read More
Frankenstein’s Index Fund August 6, 2025 / Alternative Investments, Drivers of Value, Economics, General, Investment Topics, Performance Measurement & Evaluation
How GenAI-Powered Synthetic Data Is Reshaping Investment Workflows August 6, 2025 / Artificial Intelligence, Drivers of Value, Future States, General, Investment Topics, Philosophy
